» Articles » PMID: 37101743

Cell-Penetrating D-Peptides Retain Antisense Morpholino Oligomer Delivery Activity

Overview
Specialty Biochemistry
Date 2023 Apr 27
PMID 37101743
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-penetrating peptides (CPPs) can cross the cell membrane to enter the cytosol and deliver otherwise nonpenetrant macromolecules such as proteins and oligonucleotides. For example, recent clinical trials have shown that a CPP attached to phosphorodiamidate morpholino oligomers (PMOs) resulted in higher muscle concentration, increased exon skipping, and dystrophin production relative to another study of the PMO alone in patients of Duchenne muscular dystrophy. Therefore, effective design and the study of CPPs could help enhance therapies for difficult-to-treat diseases. So far, the study of CPPs for PMO delivery has been restricted to predominantly canonical l-peptides. We hypothesized that mirror-image d-peptides could have similar PMO delivery activity as well as enhanced proteolytic stability, facilitating their characterization and quantification from biological milieu. We found that several enantiomeric peptide sequences could deliver a PMO-biotin cargo with similar activities while remaining stable against serum proteolysis. The biotin label allowed for affinity capture of fully intact PMO-peptide conjugates from whole-cell and cytosolic lysates. By profiling a mixture of these constructs in cells, we determined their relative intracellular concentrations. When combined with PMO activity, these concentrations provide a new metric for delivery efficiency, which may be useful for determining which peptide sequence to pursue in further preclinical studies.

Citing Articles

Nucleic acid drugs: recent progress and future perspectives.

Sun X, Setrerrahmane S, Li C, Hu J, Xu H Signal Transduct Target Ther. 2024; 9(1):316.

PMID: 39609384 PMC: 11604671. DOI: 10.1038/s41392-024-02035-4.


Efficacy, biodistribution and safety comparison of chemically modified antisense oligonucleotides in the retina.

Vazquez-Dominguez I, Anido A, Duijkers L, Hoppenbrouwers T, Hoogendoorn A, Koster C Nucleic Acids Res. 2024; 52(17):10447-10463.

PMID: 39119918 PMC: 11417397. DOI: 10.1093/nar/gkae686.


Advances in Ultrahigh Throughput Hit Discovery with Tandem Mass Spectrometry Encoded Libraries.

Mata J, van der Nol E, Pomplun S J Am Chem Soc. 2023; 145(34):19129-19139.

PMID: 37556835 PMC: 10472510. DOI: 10.1021/jacs.3c04899.


In-Cell Penetration Selection-Mass Spectrometry Produces Noncanonical Peptides for Antisense Delivery.

Schissel C, Farquhar C, Loas A, Malmberg A, Pentelute B ACS Chem Biol. 2023; 18(3):615-628.

PMID: 36857503 PMC: 10460143. DOI: 10.1021/acschembio.2c00920.


Approaches for evaluation of novel CPP-based cargo delivery systems.

Porosk L, Langel U Front Pharmacol. 2022; 13:1056467.

PMID: 36339538 PMC: 9634181. DOI: 10.3389/fphar.2022.1056467.

References
1.
Schissel C, Mohapatra S, Wolfe J, Fadzen C, Bellovoda K, Wu C . Deep learning to design nuclear-targeting abiotic miniproteins. Nat Chem. 2021; 13(10):992-1000. PMC: 8819921. DOI: 10.1038/s41557-021-00766-3. View

2.
Lim K, Maruyama R, Yokota T . Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther. 2017; 11:533-545. PMC: 5338848. DOI: 10.2147/DDDT.S97635. View

3.
Oehlke J, Scheller A, Wiesner B, Krause E, Beyermann M, Klauschenz E . Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim Biophys Acta. 1998; 1414(1-2):127-39. DOI: 10.1016/s0005-2736(98)00161-8. View

4.
Holden P, Horton W . Crude subcellular fractionation of cultured mammalian cell lines. BMC Res Notes. 2009; 2:243. PMC: 2802353. DOI: 10.1186/1756-0500-2-243. View

5.
Simon M, Heider P, Adamo A, Vinogradov A, Mong S, Li X . Rapid flow-based peptide synthesis. Chembiochem. 2014; 15(5):713-20. PMC: 4045704. DOI: 10.1002/cbic.201300796. View